National Health Fund

Glucophage® Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy

Retrieved on: 
Monday, February 28, 2022

The label extension now opens a tablet alternative to women who are not able or wanting to use daily injections.

Key Points: 
  • The label extension now opens a tablet alternative to women who are not able or wanting to use daily injections.
  • Ginekologia polska 2017 88:5 (244-248)
    Shub A., Lappas M.: Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of diseaseA review.
  • In adults, Glucophage may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.
  • The Glucophage product portfolio comprises: Glucophage IR (immediate release) and Glucophage XR (extended release) and Stagid (metformin embonate immediate release).

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

Retrieved on: 
Monday, October 25, 2021

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization's most-recent collaboration to advance global cancer care through recommendations based on the latest evidence and expert consensus. NCCN also works on regional guidelines adaptations, translations, and harmonizations with local providers across Sub-Saharan Africa, the Middle East and North Africa (MENA), the Caribbean, and other countries in Asia, Europe, and South America.

Key Points: 
  • PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ --The National Comprehensive Cancer Network ( NCCN )an alliance of leading cancer centers in the United Statestoday announced the publication of new NCCN Guidelines for Cervical Cancer: Poland Edition.
  • The project is led by Polish oncologists and includes the Health Technology Assessment Agency, National Health Fund, Ministry of Health representatives, and Polish patient advocacy groups.
  • The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

Retrieved on: 
Monday, October 25, 2021

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization's most-recent collaboration to advance global cancer care through recommendations based on the latest evidence and expert consensus. NCCN also works on regional guidelines adaptations, translations, and harmonizations with local providers across Sub-Saharan Africa, the Middle East and North Africa (MENA), the Caribbean, and other countries in Asia, Europe, and South America.

Key Points: 
  • PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ --The National Comprehensive Cancer Network ( NCCN )an alliance of leading cancer centers in the United Statestoday announced the publication of new NCCN Guidelines for Cervical Cancer: Poland Edition.
  • The project is led by Polish oncologists and includes the Health Technology Assessment Agency, National Health Fund, Ministry of Health representatives, and Polish patient advocacy groups.
  • The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .